Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

Gannon University and Saint Vincent Hospital announced plans Wednesday to develop two new laboratories inside Gannon's ...

Dr. Khandros will remain on the board of directors of Nutcracker Therapeutics, and Cynthia Collins will serve as executive ...

Primrose Bio, Inc. ("Primrose"), a company developing proprietary therapeutic manufacturing technologies, announces the ...

Wave Life Sciences (WVE) stock rises on plans to file for FDA accelerated approval of WVE-N531 in 2026, targeting Duchenne muscular dystrophy. Read more here.

Gannon University, Saint Vincent Hospital and First Ascent Biomedical are joining forces with one goal in mind — To advance ...

Wave Life plans a 2026 NDA filing for WVE-N531 after positive Phase 2 data in Duchenne muscular dystrophy, showing functional gains and biomarker improvements.

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased understanding of critical neurobiological features of addiction, researchers ...

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased ...

The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a ...